Perampanel effectiveness and tolerability in patients with epilepsy at long-term follow-up-Reference-Cited by-同舟云学术

Perampanel effectiveness and tolerability in patients with epilepsy at long-term follow-up

Published:2021-08 Issue: Volume:121 Page:108069
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Fernandes Mariana,Dainese Filippo,Operto Francesca,Lattanzi Simona,Matricardi Sara,Renna Rosaria^ORCID,Placidi Fabio,Paladin Francesco,Pastorino Grazia Maria Giovanna,Foschi Nicoletta,Cesaroni Elisabetta,Mercuri Nicola Biagio,Liguori Claudio

Funder

Eisai

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Clinical Neurology,Neurology

Reference36 articles.

1. Neligan A, Hauser WA, Sander JW. The epidemiology of the epilepsies. vol. 107. 1st ed. Elsevier B.V.; 2012. https://doi.org/10.1016/B978-0-444-52898-8.00006-9.

2. The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis;Kalilani;Epilepsia,2018

3. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs a 30-year longitudinal cohort study;Chen;JAMA Neurol,2018

4. Antiepileptic drug treatment of generalized tonic–clonic seizures: An evaluation of regulatory data and five criteria for drug selection;Shorvon;Epilepsy Behav,2018

5. Effectiveness of antiepileptic drug combination therapy for partial-onset seizures based on mechanisms of action;Margolis;JAMA Neurol,2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural connectivity as a predictive factor for perampanel response in patients with epilepsy;Seizure: European Journal of Epilepsy;2024-05

2. Efficacy and tolerability of perampanel in pediatric patients with Dravet syndrome;Translational Pediatrics;2024-04

3. The latest advances in the pharmacological management of focal epilepsies in children: a narrative review;Expert Review of Neurotherapeutics;2024-03-05

4. Long-term efficacy and safety of adjunctive perampanel in pediatric patients aged 4–19 years with epilepsy: a real-world study;Scientific Reports;2023-09-01

5. Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy;Frontiers in Pharmacology;2023-08-30